Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "NFI"

1028 News Found

Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance
People | April 27, 2022

Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance

Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)


SPARSH Hospital introduces high precision Surgical Imaging and Navigation system
Hospitals | April 27, 2022

SPARSH Hospital introduces high precision Surgical Imaging and Navigation system

The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors


Pharming gets positive review from UK MHRA for leniolisib
Biotech | April 26, 2022

Pharming gets positive review from UK MHRA for leniolisib

A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance
Biotech | April 25, 2022

Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance

A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Biotech | April 21, 2022

Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results

Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both


Evusheld significantly protected against symptomatic Covid-19 for at least six months
Biotech | April 21, 2022

Evusheld significantly protected against symptomatic Covid-19 for at least six months

Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group


Merck announces Joseph Romanelli will lead Merck Human Health International
News | April 21, 2022

Merck announces Joseph Romanelli will lead Merck Human Health International

In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S


Lupin engages Flutura to accelerate digitial drive using AI
News | April 21, 2022

Lupin engages Flutura to accelerate digitial drive using AI

Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes